SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci174304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Wenyan Ren und 45 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geri…. Hauptthemen laut MEDLINE: SARS-CoV-2, Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSF, National Science Foundation for Excellent Young Scholars, National Natural Science Foundation Regional Innovation and Development.
Abstract (Originalsprache)
Soluble host factors in the upper respiratory tract can serve as the first line of defense against SARS-CoV-2 infection. In this study, we described the identification and function of a human airway trypsin–like protease (HAT), capable of reducing the infectivity of ancestral SARS-CoV-2. Further, in mouse models, HAT analogue expression was upregulated by SARS-CoV-2 infection. The antiviral activity of HAT functioned through the cleavage of the SARS-CoV-2 spike glycoprotein at R682. This cleavage resulted in inhibition of the attachment of ancestral spike proteins to host cells, which inhibited the cell-cell membrane fusion process. Importantly, exogenous addition of HAT notably reduced the infectivity of ancestral SARS-CoV-2 in vivo. However, HAT was ineffective against the Delta variant and most circulating Omicron variants, including the BQ.1.1 and XBB.1.5 subvariants. We demonstrate that the P681R mutation in Delta and P681H mutation in the Omicron variants, adjacent to the R682 cleavage site, contributed to HAT resistance. Our study reports what we believe to be a novel soluble defense factor against SARS-CoV-2 and resistance of its actions in the Delta and Omicron variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, Chi…
- National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
- State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
- Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Guangzhou, Guangdong, China.
- Department of Biology and School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong, China.
- National Clinical Eye Research Center, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Förderung
- NSF
- National Science Foundation for Excellent Young Scholars
- National Natural Science Foundation Regional Innovation and Development
Zitieren
APA
Ren, W., Hong, W., Yang, J., Zou, J., Chen, L., Zhou, Y., Lei, H., Alu, A., Que, H., Gong, Y., Bi, Z., He, C., Fu, M., Peng, D., Yang, Y., Yu, W., Tang, C., Huang, Q., Yang, M., …, & Wei, X. (2024). SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease. Journal of Clinical Investigation. https://doi.org/10.1172/jci174304
Vancouver
Ren W, Hong W, Yang J, Zou J, Chen L, Zhou Y, et al. SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease. Journal of Clinical Investigation. 2024. doi:10.1172/jci174304
BibTeX
@article{Ren2024,
author = {Ren, Wenyan and Hong, Weiqi and Yang, Jingyun and Zou, Jun and Chen, Li and Zhou, Yanan and Lei, Hong and Alu, Aqu and Que, Haiying and Gong, Yanqiu and Bi, Zhenfei and He, Cai and Fu, Minyang and Peng, Dandan and Yang, Yun and Yu, Wenhai and Tang, Cong and Huang, Qing and Yang, Mengli and Li, Bai and Li, Jingmei and Wang, Junbin and Ma, Xuelei and Hu, Hongbo and Cheng, Wei and Dong, Haohao and Lei, Jian and Chen, Lu and Zhou, Xikun and Li, Jiong and Wang, Wei and Lu, Guangwen and Shen, Guobo and Yang, Li and Yang, Jinliang and Wang, Zhenling and Jia, Guowen and Su, Zhaoming and Shao, Bin and Miao, Hanpei and Yiu-Nam Lau, Johnson and Wei, Yuquan and Zhang, Kang and Dai, Lunzhi and Lu, Shuaiyao and Wei, Xiawei},
title = {SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci174304}
}
EUVIMED